![Home-Based Flu Tests as Accurate as Rapid In-Clinic Options](https://www.g2intelligence.com/wp-content/uploads/2022/03/Mar14-2022-UW-Flu-Tests-iStock-1800x1250-1.jpg)
![Home-Based Flu Tests as Accurate as Rapid In-Clinic Options](https://www.g2intelligence.com/wp-content/uploads/2022/03/Mar14-2022-UW-Flu-Tests-iStock-1800x1250-1.jpg)
![Liquid Biopsy Global Sales Expected to Hit $26.2 Billion by 2030](https://www.g2intelligence.com/wp-content/uploads/2022/03/March22.LIR_.LiquidBiopsyMarket-iStock-1800x1250-1.jpg)
Liquid Biopsy Global Sales Expected to Hit $26.2 Billion by 2030
A new report projects that the worldwide market for liquid biopsy will grow from $7.1 billion in 2020 to $26.2 billion by 2030
![CT Provides Safe, Accurate Diagnosis of Coronary Artery Disease](https://www.g2intelligence.com/wp-content/uploads/2022/03/Mar7-2022-iStock-artery-disease-diagnosis-iStock-1800x1250-1.jpg)
CT Provides Safe, Accurate Diagnosis of Coronary Artery Disease
Is cardiac computed tomography (CT) as reliable as catheterization in patients with suspected coronary artery disease? Under the leadership of Charité – Universitätsmedizin Berlin, researchers from 31 European clinical institutions worked together to address this...![Study Shows Utility of Blood Test for Prostate Cancer Risk Assessment](https://www.g2intelligence.com/wp-content/uploads/2022/03/Mar3-2022-ClevelandDx_Prostate-Cancer-Test-iStock-Prostate-Cancer_1800x1250.jpg)
Study Shows Utility of Blood Test for Prostate Cancer Risk Assessment
CLEVELAND, OH — Cleveland Diagnostics, Inc., a clinical-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, recently announced the publication of a large real-world clinical utility study in Urology Practice, a...![Biopharma M&A Expected to Rebound After Sluggish 2021](https://www.g2intelligence.com/wp-content/uploads/2022/03/March22.LIR_.MandAReport-Biopharma-iStock-1800x1250-1.jpg)
Biopharma M&A Expected to Rebound After Sluggish 2021
...